Page last updated: 2024-09-05

a 2545 and Arrhythmias, Cardiac

a 2545 has been researched along with Arrhythmias, Cardiac in 2 studies

*Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bódi, I; Frank, L; Hankovszky, OH; Hideg, K1
Arita, J; Aye, NN; Hashimoto, K; Xue, YX1

Other Studies

2 other study(ies) available for a 2545 and Arrhythmias, Cardiac

ArticleYear
New antiarrhythmic agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamindes.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:7

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation, Preclinical; Indicators and Reagents; Magnetic Resonance Spectroscopy; Nicotine; Ouabain; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship

1986
Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 358, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Flecainide; Heart Rate; Mexiletine; Models, Biological; Molecular Structure; Pyrroles

1998